Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jayashree Kalpathy-Cramer

Concepts (405)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retinopathy of Prematurity
35
2026
161
6.380
 Why?
Artificial Intelligence
38
2025
337
5.400
 Why?
Image Processing, Computer-Assisted
24
2026
774
4.520
 Why?
Glioblastoma
16
2024
348
3.240
 Why?
Brain Neoplasms
24
2024
1305
3.150
 Why?
Machine Learning
23
2026
556
2.910
 Why?
Algorithms
38
2024
1768
2.430
 Why?
Uterine Cervical Neoplasms
8
2025
288
2.370
 Why?
Diagnostic Imaging
19
2024
327
2.190
 Why?
Radiology
10
2024
171
1.930
 Why?
Natural Language Processing
7
2023
99
1.870
 Why?
Magnetic Resonance Imaging
41
2024
3737
1.830
 Why?
Information Storage and Retrieval
8
2015
120
1.710
 Why?
Retina
7
2026
314
1.570
 Why?
Neuroimaging
7
2022
281
1.520
 Why?
Glioma
8
2022
427
1.410
 Why?
Cervix Uteri
3
2025
54
1.360
 Why?
Radiotherapy Planning, Computer-Assisted
5
2016
142
1.280
 Why?
Image Interpretation, Computer-Assisted
13
2025
278
1.210
 Why?
ROC Curve
16
2026
590
1.070
 Why?
Software
10
2024
678
1.070
 Why?
Papillomavirus Infections
5
2025
382
1.060
 Why?
Humans
163
2026
141754
1.040
 Why?
Colposcopy
2
2025
22
1.000
 Why?
Optic Disk
2
2025
52
0.980
 Why?
Optical Imaging
1
2026
66
0.920
 Why?
Glaucoma
2
2025
241
0.900
 Why?
Tomography, X-Ray Computed
15
2023
2765
0.880
 Why?
Fundus Oculi
6
2026
86
0.880
 Why?
Geographic Atrophy
1
2026
91
0.870
 Why?
Severity of Illness Index
9
2024
2903
0.860
 Why?
Telemedicine
7
2023
894
0.850
 Why?
Gestational Age
18
2026
959
0.850
 Why?
Tomography, Optical Coherence
2
2025
257
0.840
 Why?
Reproducibility of Results
28
2025
3356
0.820
 Why?
Infant, Newborn
35
2026
6289
0.820
 Why?
Solitary Pulmonary Nodule
3
2021
21
0.790
 Why?
Radiology Information Systems
4
2022
33
0.790
 Why?
Privacy
1
2023
42
0.780
 Why?
Ophthalmology
5
2023
105
0.780
 Why?
Breast Neoplasms
7
2024
2257
0.770
 Why?
Diagnostic Techniques, Ophthalmological
3
2018
50
0.760
 Why?
Ophthalmoscopy
8
2024
38
0.710
 Why?
Radiologists
4
2024
52
0.710
 Why?
Bronchopulmonary Dysplasia
1
2026
403
0.670
 Why?
Sensitivity and Specificity
14
2024
1977
0.660
 Why?
Crowdsourcing
1
2020
18
0.650
 Why?
Medicine
1
2021
125
0.630
 Why?
Retinal Vessels
6
2024
75
0.620
 Why?
Breast Density
3
2024
7
0.610
 Why?
Retrospective Studies
27
2026
16374
0.610
 Why?
Mammography
4
2024
159
0.590
 Why?
Stroke
3
2023
1158
0.580
 Why?
Retinal Vein
4
2021
13
0.550
 Why?
Isocitrate Dehydrogenase
1
2017
72
0.530
 Why?
Female
59
2026
75943
0.530
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2016
109
0.500
 Why?
Lung Neoplasms
5
2021
2567
0.490
 Why?
Tumor Burden
4
2023
312
0.490
 Why?
Phenylurea Compounds
1
2016
100
0.480
 Why?
Databases, Factual
8
2021
1448
0.470
 Why?
Quinolines
1
2016
172
0.460
 Why?
Chemoradiotherapy
7
2023
234
0.460
 Why?
Gallbladder Neoplasms
3
2011
20
0.460
 Why?
Peripheral Arterial Disease
4
2023
490
0.460
 Why?
Radiography, Thoracic
5
2022
179
0.450
 Why?
Prostatic Neoplasms
5
2024
1049
0.450
 Why?
Pattern Recognition, Automated
5
2023
74
0.450
 Why?
Benchmarking
6
2024
180
0.450
 Why?
Neonatal Screening
5
2026
172
0.450
 Why?
Infant, Premature
10
2026
598
0.440
 Why?
Hypertension, Pulmonary
1
2026
1942
0.430
 Why?
Uterine Cervical Dysplasia
2
2025
45
0.430
 Why?
Delivery of Health Care
1
2021
962
0.430
 Why?
Subtraction Technique
1
2014
25
0.430
 Why?
Male
53
2026
70179
0.430
 Why?
Radiation Oncology
2
2014
86
0.420
 Why?
Neoplasm Recurrence, Local
2
2019
1078
0.420
 Why?
Retinal Artery
3
2021
17
0.420
 Why?
Early Detection of Cancer
5
2025
444
0.420
 Why?
Photography
6
2021
115
0.420
 Why?
Vocabulary, Controlled
1
2014
47
0.420
 Why?
White Matter
3
2023
148
0.410
 Why?
Phantoms, Imaging
7
2023
150
0.400
 Why?
Multimodal Imaging
1
2014
120
0.400
 Why?
Datasets as Topic
5
2021
125
0.380
 Why?
Middle Aged
32
2025
34647
0.370
 Why?
Aged
30
2025
24746
0.370
 Why?
Survival Analysis
4
2016
1320
0.360
 Why?
Cerebral Blood Volume
3
2020
5
0.360
 Why?
Contrast Media
9
2020
470
0.350
 Why?
Radiotherapy, Conformal
1
2011
73
0.350
 Why?
Internet
2
2014
690
0.350
 Why?
Mass Screening
4
2025
1313
0.350
 Why?
Adrenoleukodystrophy
2
2023
9
0.340
 Why?
Clinical Competence
2
2016
1205
0.340
 Why?
Proportional Hazards Models
4
2011
1268
0.330
 Why?
Brain
8
2021
2868
0.320
 Why?
Radiographic Image Interpretation, Computer-Assisted
2
2023
119
0.320
 Why?
Precision Medicine
3
2024
434
0.320
 Why?
Medical Informatics
4
2020
101
0.310
 Why?
Head and Neck Neoplasms
5
2020
555
0.310
 Why?
Neoplasms
7
2024
2747
0.300
 Why?
Database Management Systems
1
2008
51
0.290
 Why?
User-Computer Interface
4
2015
164
0.280
 Why?
Radiotherapy, Adjuvant
1
2008
219
0.280
 Why?
Endovascular Procedures
2
2023
356
0.280
 Why?
Automation
5
2020
100
0.270
 Why?
Observer Variation
4
2024
357
0.270
 Why?
Infant
12
2026
9843
0.260
 Why?
Adult
27
2025
39391
0.260
 Why?
Lung
6
2022
4137
0.260
 Why?
Prognosis
9
2024
4080
0.260
 Why?
Radiography
5
2022
844
0.240
 Why?
Risk Factors
9
2026
10482
0.230
 Why?
Diffusion Magnetic Resonance Imaging
2
2018
156
0.230
 Why?
Endoscopy, Gastrointestinal
1
2007
232
0.230
 Why?
Antineoplastic Agents
1
2016
2169
0.230
 Why?
Predictive Value of Tests
5
2025
2075
0.230
 Why?
Uncertainty
1
2026
139
0.230
 Why?
Rectal Neoplasms
2
2021
152
0.230
 Why?
Oropharyngeal Neoplasms
2
2015
55
0.230
 Why?
Reference Standards
7
2021
186
0.220
 Why?
Neoplasm Grading
3
2024
316
0.210
 Why?
Adenocarcinoma in Situ
1
2023
1
0.210
 Why?
Forecasting
3
2019
384
0.210
 Why?
Statistics as Topic
2
2014
302
0.200
 Why?
Postoperative Care
2
2019
280
0.200
 Why?
Ranibizumab
1
2023
21
0.200
 Why?
Imaging, Three-Dimensional
4
2023
569
0.200
 Why?
Radiotherapy, Intensity-Modulated
4
2016
137
0.190
 Why?
Neovascularization, Pathologic
3
2024
296
0.190
 Why?
Diagnosis, Computer-Assisted
2
2021
89
0.190
 Why?
Biomedical Research
3
2024
708
0.190
 Why?
Long QT Syndrome
1
2023
70
0.190
 Why?
Myeloid-Derived Suppressor Cells
1
2023
73
0.190
 Why?
Documentation
2
2015
199
0.190
 Why?
Macular Degeneration
1
2024
186
0.190
 Why?
Oxygen
2
2021
992
0.190
 Why?
Computer Communication Networks
2
2020
33
0.180
 Why?
Quality Assurance, Health Care
2
2014
333
0.180
 Why?
Rheumatic Diseases
1
2022
92
0.180
 Why?
Diverticulitis
1
2021
8
0.180
 Why?
Patient-Specific Modeling
2
2024
42
0.180
 Why?
Biomarkers
4
2018
4190
0.170
 Why?
Cohort Studies
6
2022
5815
0.170
 Why?
Hospital Units
1
2021
32
0.170
 Why?
Racism
1
2023
139
0.170
 Why?
Musculoskeletal System
1
2021
49
0.170
 Why?
Intestinal Obstruction
1
2021
53
0.170
 Why?
India
1
2021
208
0.170
 Why?
Dacarbazine
3
2015
98
0.170
 Why?
Tibial Meniscus Injuries
1
2021
49
0.160
 Why?
Perfusion Imaging
1
2020
62
0.160
 Why?
Microcirculation
2
2017
150
0.160
 Why?
Radiometry
1
2020
54
0.160
 Why?
Hyperemia
1
2020
49
0.160
 Why?
Health Information Exchange
1
2020
24
0.160
 Why?
Medical Records Systems, Computerized
2
2013
96
0.160
 Why?
Biomarkers, Tumor
3
2016
1258
0.160
 Why?
Carcinoma, Squamous Cell
2
2015
645
0.160
 Why?
Signal Processing, Computer-Assisted
2
2017
151
0.160
 Why?
Brain Ischemia
1
2023
350
0.160
 Why?
Brain Diseases
1
2021
149
0.160
 Why?
Area Under Curve
4
2021
324
0.160
 Why?
Cerebellar Neoplasms
1
2022
179
0.150
 Why?
Lung Injury
1
2022
227
0.150
 Why?
Positron Emission Tomography Computed Tomography
1
2020
110
0.150
 Why?
Low Back Pain
1
2021
108
0.150
 Why?
Vascular Endothelial Growth Factor A
2
2023
554
0.150
 Why?
Hematopoietic Stem Cell Transplantation
2
2023
671
0.150
 Why?
Medulloblastoma
1
2022
218
0.150
 Why?
Appendicitis
1
2021
146
0.150
 Why?
Antineoplastic Agents, Alkylating
2
2018
71
0.150
 Why?
Aneurysm, Ruptured
1
2019
37
0.150
 Why?
Treatment Outcome
8
2023
11181
0.150
 Why?
Capillary Permeability
1
2019
149
0.150
 Why?
Age Determination by Skeleton
1
2018
15
0.150
 Why?
Blood-Brain Barrier
2
2017
145
0.150
 Why?
Drug Resistance, Neoplasm
1
2024
833
0.150
 Why?
Models, Biological
4
2024
1828
0.150
 Why?
Cone-Beam Computed Tomography
1
2018
31
0.140
 Why?
Colonic Neoplasms
1
2021
246
0.140
 Why?
Linear Models
1
2021
858
0.140
 Why?
Intracranial Aneurysm
1
2019
100
0.140
 Why?
Arteries
2
2019
262
0.140
 Why?
Ventricular Dysfunction, Right
1
2021
243
0.140
 Why?
Antibodies, Monoclonal, Humanized
1
2024
913
0.140
 Why?
Medical Record Linkage
1
2018
68
0.140
 Why?
Global Health
1
2021
387
0.140
 Why?
Prospective Studies
7
2023
7777
0.130
 Why?
Gadolinium
1
2017
81
0.130
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2019
1793
0.130
 Why?
Polysaccharides, Bacterial
1
2017
70
0.130
 Why?
Bayes Theorem
2
2016
418
0.130
 Why?
Respiratory Insufficiency
1
2021
325
0.130
 Why?
Diagnosis, Differential
3
2019
1502
0.130
 Why?
Preoperative Period
1
2017
144
0.130
 Why?
Gray Matter
1
2018
87
0.130
 Why?
Patient Readmission
1
2022
708
0.130
 Why?
North America
3
2024
307
0.130
 Why?
Skin Diseases, Genetic
1
2016
13
0.130
 Why?
Computer Simulation
5
2024
1015
0.130
 Why?
Chronic Pain
1
2021
280
0.120
 Why?
Pharyngeal Muscles
1
2016
6
0.120
 Why?
Blood Vessels
1
2017
180
0.120
 Why?
Nasopharyngeal Neoplasms
1
2016
20
0.120
 Why?
SEER Program
3
2011
221
0.120
 Why?
Angiogenesis Inhibitors
2
2016
230
0.120
 Why?
National Cancer Institute (U.S.)
3
2020
48
0.120
 Why?
Blood Volume Determination
1
2015
5
0.120
 Why?
Risk Assessment
4
2025
3508
0.120
 Why?
Vascular Malformations
1
2016
51
0.120
 Why?
Liver Cirrhosis
1
2017
282
0.120
 Why?
Acute Kidney Injury
1
2023
820
0.120
 Why?
Positron-Emission Tomography
4
2021
310
0.110
 Why?
Fibrosis
1
2017
542
0.110
 Why?
Cranial Irradiation
1
2015
85
0.110
 Why?
Physical Phenomena
1
2014
13
0.110
 Why?
Organs at Risk
1
2014
35
0.110
 Why?
Radiation Injuries
1
2016
149
0.110
 Why?
Societies, Medical
3
2024
859
0.110
 Why?
Birth Weight
3
2023
515
0.110
 Why?
Brachial Plexus
1
2014
33
0.110
 Why?
Aged, 80 and over
5
2018
7923
0.110
 Why?
Longitudinal Studies
2
2019
2938
0.110
 Why?
Tumor Microenvironment
1
2018
703
0.110
 Why?
Administration, Oral
1
2016
803
0.110
 Why?
Chemoradiotherapy, Adjuvant
2
2011
44
0.110
 Why?
Joint Instability
1
2016
168
0.110
 Why?
Deglutition Disorders
1
2016
151
0.110
 Why?
Mutation
3
2024
4015
0.100
 Why?
Computer-Assisted Instruction
1
2014
68
0.100
 Why?
Arteriovenous Malformations
1
2013
29
0.100
 Why?
Computer Literacy
1
2013
5
0.100
 Why?
Bias
3
2024
229
0.100
 Why?
Health Information Systems
1
2013
17
0.100
 Why?
Young Adult
7
2018
13749
0.090
 Why?
Survival Rate
3
2018
1972
0.090
 Why?
Terminology as Topic
1
2014
244
0.090
 Why?
Otorhinolaryngologic Neoplasms
1
2011
2
0.090
 Why?
Nomograms
1
2011
58
0.090
 Why?
Feasibility Studies
2
2014
1027
0.090
 Why?
Workload
1
2013
166
0.090
 Why?
Research Design
2
2014
1146
0.080
 Why?
Child
8
2024
22414
0.080
 Why?
Support Vector Machine
2
2021
38
0.080
 Why?
Muscle, Skeletal
1
2020
1757
0.080
 Why?
Emergency Service, Hospital
1
2021
2193
0.080
 Why?
Liver
1
2017
1820
0.080
 Why?
Periodicals as Topic
1
2012
217
0.070
 Why?
Papillomaviridae
2
2023
133
0.070
 Why?
Oregon
1
2008
79
0.070
 Why?
Exercise
1
2020
2112
0.070
 Why?
Total Quality Management
1
2008
61
0.070
 Why?
United States
5
2024
15310
0.070
 Why?
Lower Extremity
2
2023
439
0.070
 Why?
MEDLINE
1
2008
23
0.070
 Why?
Dilatation, Pathologic
2
2018
60
0.070
 Why?
Follow-Up Studies
3
2024
5212
0.070
 Why?
Breast
2
2019
158
0.070
 Why?
Protein Kinase Inhibitors
1
2013
919
0.070
 Why?
Electronic Health Records
1
2015
1132
0.060
 Why?
Monte Carlo Method
2
2017
150
0.060
 Why?
Cluster Analysis
1
2007
521
0.060
 Why?
Clinical Protocols
2
2019
273
0.060
 Why?
Tanzania
1
2025
59
0.060
 Why?
Vaginal Smears
1
2025
61
0.060
 Why?
Proof of Concept Study
1
2024
85
0.050
 Why?
Critical Illness
2
2021
837
0.050
 Why?
Netherlands
1
2024
87
0.050
 Why?
Intensive Care Units, Neonatal
2
2018
270
0.050
 Why?
Kinetics
2
2019
1655
0.050
 Why?
Physicians
1
2013
942
0.050
 Why?
Brain Infarction
1
2023
23
0.050
 Why?
Ethers, Cyclic
1
2023
11
0.050
 Why?
DNA, Viral
1
2025
367
0.050
 Why?
Troponin T
1
2023
66
0.050
 Why?
Benzofurans
1
2023
25
0.050
 Why?
Models, Theoretical
2
2021
584
0.050
 Why?
X-Rays
1
2022
31
0.050
 Why?
DNA Helicases
1
2024
142
0.050
 Why?
Data Curation
1
2022
19
0.050
 Why?
Smartphone
1
2023
91
0.050
 Why?
Adrenal Glands
1
2022
80
0.050
 Why?
Quinazolines
2
2013
260
0.050
 Why?
Logistic Models
2
2021
2092
0.050
 Why?
Cross-Sectional Studies
2
2024
5697
0.050
 Why?
Limb Salvage
1
2022
65
0.050
 Why?
Health Services
1
2022
118
0.050
 Why?
Antineoplastic Agents, Immunological
1
2024
195
0.050
 Why?
Vagina
1
2024
195
0.040
 Why?
Utilization Review
1
2021
41
0.040
 Why?
Receptors, GABA
1
2021
14
0.040
 Why?
Edema
1
2022
131
0.040
 Why?
Nepal
1
2021
31
0.040
 Why?
Neoadjuvant Therapy
1
2024
424
0.040
 Why?
Genetic Therapy
1
2023
315
0.040
 Why?
Massachusetts
1
2021
174
0.040
 Why?
Case-Control Studies
2
2019
3597
0.040
 Why?
Early Diagnosis
1
2021
244
0.040
 Why?
Clinical Trials as Topic
2
2016
1057
0.040
 Why?
Genotype
1
2025
1866
0.040
 Why?
Abdomen
1
2021
136
0.040
 Why?
Seizures
1
2024
442
0.040
 Why?
Incidence
2
2020
2806
0.040
 Why?
Internationality
1
2021
158
0.040
 Why?
Ankle
1
2020
61
0.040
 Why?
Indoles
2
2013
478
0.040
 Why?
Cell Cycle Proteins
1
2024
632
0.040
 Why?
Models, Statistical
2
2016
671
0.040
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2019
29
0.040
 Why?
Hematopoietic Stem Cells
1
2023
411
0.040
 Why?
Disease Progression
2
2020
2800
0.040
 Why?
Hand Bones
1
2018
3
0.040
 Why?
Infant, Low Birth Weight
1
2020
146
0.040
 Why?
Risk
1
2021
907
0.040
 Why?
Nuclear Proteins
1
2024
719
0.040
 Why?
Bevacizumab
1
2019
139
0.040
 Why?
Quality Control
1
2019
171
0.040
 Why?
Arthroscopy
1
2021
245
0.040
 Why?
Genomics
1
2024
815
0.040
 Why?
Radiation Exposure
1
2019
55
0.040
 Why?
Ventricular Function, Right
1
2021
283
0.040
 Why?
Reference Values
1
2020
807
0.040
 Why?
Hyperlipidemias
1
2019
125
0.040
 Why?
Medical Oncology
1
2021
317
0.040
 Why?
Hemizygote
1
2017
5
0.030
 Why?
Carbon Tetrachloride
1
2017
13
0.030
 Why?
Diabetic Retinopathy
1
2020
201
0.030
 Why?
Half-Life
1
2017
146
0.030
 Why?
Diffusion
1
2017
121
0.030
 Why?
Permeability
1
2017
166
0.030
 Why?
Chemotherapy, Adjuvant
1
2018
381
0.030
 Why?
Skull
1
2018
151
0.030
 Why?
Asymptomatic Diseases
1
2017
92
0.030
 Why?
Outpatients
1
2021
421
0.030
 Why?
Ecosystem
1
2022
583
0.030
 Why?
Tissue Distribution
1
2017
330
0.030
 Why?
Signal-To-Noise Ratio
1
2016
67
0.030
 Why?
Information Dissemination
1
2019
224
0.030
 Why?
Expert Systems
1
2016
4
0.030
 Why?
Prostate
1
2017
173
0.030
 Why?
Respiration, Artificial
1
2021
685
0.030
 Why?
Palate, Soft
1
2016
15
0.030
 Why?
Heart Ventricles
1
2021
753
0.030
 Why?
Dose-Response Relationship, Radiation
1
2016
144
0.030
 Why?
Transcription Factors
1
2024
1712
0.030
 Why?
Evaluation Studies as Topic
1
2016
175
0.030
 Why?
Video Recording
1
2017
198
0.030
 Why?
Antineoplastic Protocols
1
2015
6
0.030
 Why?
Molecular Imaging
1
2016
55
0.030
 Why?
Platelet Count
1
2015
89
0.030
 Why?
Magnetic Resonance Angiography
1
2017
249
0.030
 Why?
Perfusion
1
2016
228
0.030
 Why?
Radiotherapy Dosage
1
2016
281
0.030
 Why?
Motion
1
2015
101
0.030
 Why?
Cerebrovascular Circulation
1
2017
271
0.030
 Why?
Diffusion Tensor Imaging
1
2015
78
0.030
 Why?
Disease-Free Survival
1
2016
718
0.030
 Why?
Intensive Care Units
1
2021
871
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1634
0.030
 Why?
Thoracic Neoplasms
1
2014
39
0.030
 Why?
Mass Spectrometry
1
2017
740
0.030
 Why?
Comorbidity
1
2019
1664
0.030
 Why?
Image Enhancement
1
2015
191
0.030
 Why?
Carcinoma
1
2016
230
0.030
 Why?
DNA Modification Methylases
1
2013
17
0.030
 Why?
DNA Repair Enzymes
1
2013
29
0.030
 Why?
Congresses as Topic
1
2015
230
0.020
 Why?
Argentina
1
2013
28
0.020
 Why?
Child, Preschool
2
2018
11512
0.020
 Why?
Pandemics
1
2021
1656
0.020
 Why?
Statistics, Nonparametric
1
2013
434
0.020
 Why?
Molecular Targeted Therapy
1
2016
420
0.020
 Why?
Fluorescein Angiography
1
2013
175
0.020
 Why?
Adolescent
3
2018
22130
0.020
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
231
0.020
 Why?
Life Tables
1
2011
20
0.020
 Why?
Smoking
1
2019
1603
0.020
 Why?
Effect Modifier, Epidemiologic
1
2011
9
0.020
 Why?
Hemodynamics
1
2016
1100
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2013
855
0.020
 Why?
Tumor Suppressor Proteins
1
2013
326
0.020
 Why?
Time Factors
1
2022
6966
0.020
 Why?
Hospitalization
1
2021
2264
0.020
 Why?
Educational Status
1
2013
464
0.020
 Why?
Pregnancy
1
2023
7092
0.020
 Why?
Polymerase Chain Reaction
1
2013
1056
0.020
 Why?
Probability
1
2011
309
0.020
 Why?
Hypertension
1
2019
1254
0.020
 Why?
Diabetes Mellitus
1
2019
1077
0.020
 Why?
Lymphatic Metastasis
1
2011
326
0.020
 Why?
Pilot Projects
1
2015
1826
0.020
 Why?
Rats
1
2017
5637
0.020
 Why?
Kaplan-Meier Estimate
1
2011
910
0.020
 Why?
PubMed
1
2008
11
0.020
 Why?
Ultrasonography
1
2012
761
0.020
 Why?
Disease Models, Animal
1
2017
4421
0.020
 Why?
Neoplasm Staging
1
2011
1401
0.020
 Why?
Attitude of Health Personnel
1
2013
1183
0.010
 Why?
Internship and Residency
1
2014
1240
0.010
 Why?
Age Factors
1
2011
3294
0.010
 Why?
Mice
1
2017
18109
0.010
 Why?
Animals
1
2017
37749
0.010
 Why?
Kalpathy-Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (405) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)